Proton pump inhibitors (PPIs) are commonly used medications for treating heartburn, acid reflux, and gastroesophageal reflux disease (GERD). Popular brands like Prilosec, Nexium, and Prevacid are well-known to many people who struggle with these conditions.
In the United States, about 10% of adults rely on these drugs every day to manage symptoms that can be very uncomfortable. However, recent research from the University of California San Diego is raising serious concerns about the long-term safety of these medications, especially when it comes to kidney health.
The study, published in Scientific Reports, analyzed data from the FDA Adverse Event Reporting System (FAERS), which includes more than 10 million records of side effects reported by patients.
The researchers focused on around 43,000 patients who only used PPIs. For comparison, they also looked at about 8,000 patients who took histamine-2 receptor blockers, like Zantac or Pepcid. These drugs also treat heartburn but work differently from PPIs.
The results were surprising and concerning. Among PPI users, 5.6% reported kidney-related problems, while only 0.7% of those taking histamine-2 receptor blockers experienced similar issues. The difference is quite large, suggesting that PPI users are far more likely to suffer from kidney problems.
The study also found that people who took PPIs were 28.4 times more likely to report having chronic kidney disease compared to those who took histamine-2 receptor blockers. This is a staggering difference and suggests a strong link between long-term PPI use and kidney damage.
Beyond chronic kidney disease, PPI users were also at higher risk for acute kidney injury, which is a sudden loss of kidney function, and end-stage renal disease, which is when the kidneys stop working entirely. There were also more reports of electrolyte imbalances, which can affect the body’s ability to function properly.
These findings add to a growing list of concerns about PPI safety. In fact, this is not the first time researchers have found potential risks associated with these drugs. A study from the same university in 2017 found that long-term PPI use was linked to chronic liver disease.
Together, these studies suggest that while PPIs are very effective at reducing stomach acid and relieving symptoms, they may also come with serious health risks that need to be considered.
PPIs work by blocking an enzyme in the stomach that produces acid. This helps reduce heartburn and prevent damage to the esophagus. For many people, PPIs are life-changing medications that allow them to eat and live more comfortably.
However, because they are available over the counter and often used for long periods of time, many people may not realize the risks involved. Taking these medications for too long or without medical supervision can increase the chances of serious kidney problems.
Healthcare providers are now being urged to think carefully about the risks and benefits of PPIs, especially for patients who may already be at risk for kidney disease.
Doctors are also encouraged to monitor their patients more closely for signs of kidney problems if they are taking PPIs regularly. This might include routine blood tests to check kidney function and watching for symptoms like swelling, fatigue, or changes in urine.
For patients, this research highlights the importance of talking to their doctors about the risks of long-term PPI use. If you are using PPIs regularly, it may be a good idea to discuss whether you still need them or if there are other treatment options available.
In some cases, lifestyle changes such as adjusting diet, losing weight, and avoiding trigger foods can reduce the need for medications. Other options like histamine-2 receptor blockers may also be considered as they seem to have fewer risks for kidney health.
The findings from this study represent a critical step in understanding the long-term effects of these widely used drugs. As more research emerges, doctors and patients can make more informed decisions about the safest and most effective ways to manage heartburn and acid reflux without putting their kidneys at risk.
The study’s lead researcher, Ruben Abagyan, emphasizes that while PPIs are important for treating serious acid-related conditions, they should be used with caution, particularly for long-term treatment.
In summary, while proton pump inhibitors are effective for managing stomach acid and relieving discomfort, their long-term use may come with serious risks to kidney health.
Patients who rely on these medications should be aware of the potential dangers and work with their doctors to find the safest approach to managing their symptoms. Understanding these risks can help prevent serious health problems and encourage safer use of these powerful medications.
If you care about kidney health, please read studies about drug that prevents kidney failure in diabetes, and drinking coffee could help reduce risk of kidney injury.
For more information about kidney health, please see recent studies about foods that may prevent recurrence of kidney stones, and common painkillers may harm heart, kidneys and more.
Copyright © 2025 Knowridge Science Report. All rights reserved.
